Patents by Inventor Renlin WANG

Renlin WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic compounds as BCR-ABL inhibitors
    Patent number: 11987575
    Abstract: The present disclosure provides compounds represented by Formula I, or an enantiomer or diastereomer, or a pharmaceutically acceptable salt thereof, wherein X, Y, Z, L, Ar, R1, R2, R3 R4, R5, R6, m, and p are defined herein. Compounds of Formula I are BCR-ABL inhibitors. BCR-ABL inhibitors are useful for the treatment of cancer and other diseases.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: May 21, 2024
    Assignees: ASCENTAGE PHARMA (SUZHOU) CO., LTD., ASCENTAGE PHARMA GROUP CORP, LIMITED
    Inventors: Yunlong Zhou, Guozhi Tang, Chao Li, Fang Liu, Yu Jing, Renlin Wang
  • HETEROCYCLIC COMPOUNDS AS BCR-ABL INHIBITORS
    Publication number: 20220332701
    Abstract: The present disclosure provides compounds represented by Formula I: wherein R1, R2a, R2b, R2c, R2d, R3, R4a, R4b, A, L, X, Y, Z, and are as defined in the specification, and the pharmaceutically acceptable salts and solvates thereof. Compounds of Formula I are BCR-ABL inhibitors. BCR-ABL inhibitors are useful for the treatment of cancer and other diseases.
    Type: Application
    Filed: July 29, 2020
    Publication date: October 20, 2022
    Inventors: Yunlong Zhou, Guozhi TANG, Chao LI, Fang LIU, Yu JING, Renlin WANG, Lingling JIAO
  • NOVEL TRICYCLIC COMPOUNDS AS BCR-ABL INHIBITORS
    Publication number: 20220306608
    Abstract: The present disclosure provides compounds represented by Formula I, or an enantiomer or diastereomer, or a pharmaceutically acceptable salt thereof, wherein X, Y, Z, L, Ar, R1, R2, R3 R4, R5, R6, m, and p are defined herein. Compounds of Formula I are BCR-ABL inhibitors. BCR-ABL inhibitors are useful for the treatment of cancer and other diseases.
    Type: Application
    Filed: July 29, 2020
    Publication date: September 29, 2022
    Inventors: Yunlong Zhou, Guozhi TANG, Chao LI, Frang LIU, Yu JING, Renlin WANG